{"id":1016095,"date":"2026-11-02T11:13:31","date_gmt":"2026-11-02T16:13:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/"},"modified":"2026-11-02T11:13:31","modified_gmt":"2026-11-02T16:13:31","slug":"lyell-immunopharma-to-participate-in-november-investor-events","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/","title":{"rendered":"Lyell Immunopharma To Participate in November Investor Events"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SOUTH SAN FRANCISCO, Calif., Nov.  02, 2026  (GLOBE NEWSWIRE) &#8212; Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior management team will participate in the following investor events:<\/p>\n<p>\n        <strong>Goldman Sachs\u2019 RxChange Series: Framing Lyell\u2019s next-generation lymphoma CAR-T data in 4Q<\/strong><br \/>\n        <br \/>Format: Fireside Chat<br \/>Featured Speaker: Alexander P. Boardman, MD, Associate Physician, Division of Hematology\/Oncology, Mass General Brigham Cancer Institute; Faculty of Medicine, Harvard Medical School<br \/>Date &amp; Time: Thursday, November 5, 2026 at 11:00 am ET<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FkXlCvgc1EjUNh3RB5LfIZIhteSoTz_n6hbVR29vLRc4T3TlZFqnfStz3d32saKz050L51wZ3vhw706jSLxckaweF3LmakZY7DxsqRzXnzEx_f1-NBlo35SEaT014CtUSGJ4Y5-sBMT8gW-VS9NQQw==\" rel=\"nofollow\" target=\"_blank\">Here<\/a><\/p>\n<p>\n        <strong>Stifel 2026 Healthcare Conference<\/strong><br \/>\n        <br \/>Format: Fireside Chat and 1&#215;1 Meetings <br \/>Date &amp; Time: Tuesday, November 10, 2026, at 4:00 pm ET<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FkXlCvgc1EjUNh3RB5LfIec8NaCVWG7-Xcjk6Nt8C_9GASgPRrtA2jNn_YnMGRRdYGp4eSO8yGX4cPiBbYx7VNnnCJd5MrRAq0EOiLY07eTebiubSs-vjFq-XX7urMfq8k432CgEosHizCepSRitiw==\" rel=\"nofollow\" target=\"_blank\">Here<\/a><\/p>\n<p>\n        <strong>2026 Jefferies Global Healthcare Conference<\/strong><br \/>\n        <br \/>Format: 1&#215;1 Meetings<br \/>Date: Wednesday, November 18, 2026<\/p>\n<p>A live webcast and subsequent replay of the Stifel fireside chat will be available in the Investors section of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=e6ZrDyvS5m6ubNUPBqRkGPygkYvx-1Uv5QIziFq9agf_R33coBwRjePlLJYdi8h7wZXxSHqQ45EO3obzZMe_xQ==\" rel=\"nofollow\" target=\"_blank\">www.lyell.com<\/a>.<\/p>\n<p>\n        <strong>About Lyell Immunopharma, Inc.<\/strong>\n      <\/p>\n<p>Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors. To realize the potential of cell therapy for cancer, Lyell utilizes a suite of technologies to arm CAR T cells with enhancements needed to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical responses, including the ability to resist exhaustion, maintain qualities of durable stemness and function in the hostile tumor microenvironment. Lyell\u2019s proprietary LyFE Manufacturing Center\u2122 has commercial launch capability and is expected to have the capacity to manufacture more than 1,200 CAR T-cell doses per year. To learn more, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=e6ZrDyvS5m6ubNUPBqRkGKNaB_XKuIPmSqd4sVxNYURTMoRhX3MohGENk_why27qQ-QcN9AoccumZ3nhp-DqDQ==\" rel=\"nofollow\" target=\"_blank\">www.lyell.com<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>Lyell Investor Relations<br \/>IR@lyell.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzkwMyM3OTM5NDExIzIxODc2NTg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjhkNzYwNzMtNTZjNC00NjUzLWI4ZDQtMWQ2ZmVhMTY0NzFlLTExOTkyMTEtMjAyNi0xMS0wMi1lbg==\/tiny\/Lyell-Immunopharma-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior management team will participate in the following investor events: Goldman Sachs\u2019 RxChange Series: Framing Lyell\u2019s next-generation lymphoma CAR-T data in 4Q Format: Fireside ChatFeatured Speaker: Alexander P. Boardman, MD, Associate Physician, Division of Hematology\/Oncology, Mass General Brigham Cancer Institute; Faculty of Medicine, Harvard Medical SchoolDate &amp; Time: Thursday, November 5, 2026 at 11:00 am ETWebcast Link: Here Stifel 2026 Healthcare Conference Format: Fireside Chat and 1&#215;1 Meetings Date &amp; Time: Tuesday, November 10, 2026, at 4:00 pm ETWebcast Link: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lyell Immunopharma To Participate in November Investor Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1016095","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lyell Immunopharma To Participate in November Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lyell Immunopharma To Participate in November Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior management team will participate in the following investor events: Goldman Sachs\u2019 RxChange Series: Framing Lyell\u2019s next-generation lymphoma CAR-T data in 4Q Format: Fireside ChatFeatured Speaker: Alexander P. Boardman, MD, Associate Physician, Division of Hematology\/Oncology, Mass General Brigham Cancer Institute; Faculty of Medicine, Harvard Medical SchoolDate &amp; Time: Thursday, November 5, 2026 at 11:00 am ETWebcast Link: Here Stifel 2026 Healthcare Conference Format: Fireside Chat and 1&#215;1 Meetings Date &amp; Time: Tuesday, November 10, 2026, at 4:00 pm ETWebcast Link: &hellip; Continue reading &quot;Lyell Immunopharma To Participate in November Investor Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-02T16:13:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzkwMyM3OTM5NDExIzIxODc2NTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lyell-immunopharma-to-participate-in-november-investor-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lyell-immunopharma-to-participate-in-november-investor-events\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lyell Immunopharma To Participate in November Investor Events\",\"datePublished\":\"2026-11-02T16:13:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lyell-immunopharma-to-participate-in-november-investor-events\\\/\"},\"wordCount\":277,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lyell-immunopharma-to-participate-in-november-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2NzkwMyM3OTM5NDExIzIxODc2NTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lyell-immunopharma-to-participate-in-november-investor-events\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lyell-immunopharma-to-participate-in-november-investor-events\\\/\",\"name\":\"Lyell Immunopharma To Participate in November Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lyell-immunopharma-to-participate-in-november-investor-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lyell-immunopharma-to-participate-in-november-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2NzkwMyM3OTM5NDExIzIxODc2NTg=\",\"datePublished\":\"2026-11-02T16:13:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lyell-immunopharma-to-participate-in-november-investor-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lyell-immunopharma-to-participate-in-november-investor-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lyell-immunopharma-to-participate-in-november-investor-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2NzkwMyM3OTM5NDExIzIxODc2NTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2NzkwMyM3OTM5NDExIzIxODc2NTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lyell-immunopharma-to-participate-in-november-investor-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lyell Immunopharma To Participate in November Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lyell Immunopharma To Participate in November Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"Lyell Immunopharma To Participate in November Investor Events - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior management team will participate in the following investor events: Goldman Sachs\u2019 RxChange Series: Framing Lyell\u2019s next-generation lymphoma CAR-T data in 4Q Format: Fireside ChatFeatured Speaker: Alexander P. Boardman, MD, Associate Physician, Division of Hematology\/Oncology, Mass General Brigham Cancer Institute; Faculty of Medicine, Harvard Medical SchoolDate &amp; Time: Thursday, November 5, 2026 at 11:00 am ETWebcast Link: Here Stifel 2026 Healthcare Conference Format: Fireside Chat and 1&#215;1 Meetings Date &amp; Time: Tuesday, November 10, 2026, at 4:00 pm ETWebcast Link: &hellip; Continue reading \"Lyell Immunopharma To Participate in November Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-02T16:13:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzkwMyM3OTM5NDExIzIxODc2NTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lyell Immunopharma To Participate in November Investor Events","datePublished":"2026-11-02T16:13:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/"},"wordCount":277,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzkwMyM3OTM5NDExIzIxODc2NTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/","name":"Lyell Immunopharma To Participate in November Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzkwMyM3OTM5NDExIzIxODc2NTg=","datePublished":"2026-11-02T16:13:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzkwMyM3OTM5NDExIzIxODc2NTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzkwMyM3OTM5NDExIzIxODc2NTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lyell-immunopharma-to-participate-in-november-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lyell Immunopharma To Participate in November Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016095","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1016095"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016095\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1016095"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1016095"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1016095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}